BERCX
Price
$17.96
Change
+$0.06 (+0.34%)
Updated
Sep 5 closing price
Net Assets
21.24M
MVCAX
Price
$32.37
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Net Assets
17.32B
Interact to see
Advertisement

BERCX vs MVCAX

Header iconBERCX vs MVCAX Comparison
Open Charts BERCX vs MVCAXBanner chart's image
Carillon Chartwell Mid Cap Value I
Price$17.96
Change+$0.06 (+0.34%)
VolumeN/A
Net Assets21.24M
MFS Mid Cap Value A
Price$32.37
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets17.32B
BERCX vs MVCAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BERCX vs. MVCAX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BERCX is a Hold and MVCAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 17.3B vs. BERCX (21.2M). BERCX pays higher dividends than MVCAX: BERCX (0.93) vs MVCAX (0.84). BERCX was incepted earlier than MVCAX: BERCX (23 years) vs MVCAX (24 years). BERCX (1.35) is less costly to investors than MVCAX (1.00). BERCX is a more actively managed with annual turnover of: 51.00 vs. MVCAX (27.00). BERCX (1000) and MVCAX (1000) have matching initial minimum investment requirements. BERCX annual gain was more profitable for investors over the last year : -1.97 vs. MVCAX (-2.57). MVCAX return over 5 years is better than : 52.00 vs. BERCX (43.31).
BERCXMVCAXBERCX / MVCAX
Total Expense Ratio0.900.9991%
Annual Report Gross Expense Ratio1.351.00135%
Fund Existence23 years24 years-
Gain YTD6.6115.508120%
Front LoadN/A6%-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets21.2M17.3B0%
Annual Yield % from dividends0.930.84111%
Returns for 1 year-1.97-2.5777%
Returns for 3 years11.4418.3662%
Returns for 5 years43.3152.0083%
Returns for 10 years44.3475.5759%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TPST10.990.96
+9.57%
Tempest Therapeutics Inc
FBIN60.821.77
+3.00%
Fortune Brands Innovations
STGW5.570.05
+0.91%
Stagwell
GSRT10.35-0.01
-0.10%
GSR III Acquisition Corp
LLY727.21-15.70
-2.11%
Eli Lilly & Co